Is This Dividend Growth Stock a Buy Right Now?
There are few guarantees in life, but for those seeking to grow richer over time, buying quality, shareholder-friendly businesses is likely the most surefire strategy. Boasting 45 consecutive years of dividend growth, medical device maker Medtronic (NYSE: MDT) has a reputation for consistently sending more cash to its shareholders' brokerage accounts.
But should dividend growth investors add the stock to their portfolios at this time? Let's delve into Medtronic's fundamentals and valuation to find out.
With 49,000 patents in its portfolio for medical devices treating 70-plus conditions ranging from diabetes to Parkinson's disease, Medtronic has a dynamic business. That's precisely how the company served almost 80 million patients in its previous fiscal year.
Source Fool.com
